New Treatment Options for Relapsed/Recurrent DLBCL: Impact on Sequencing Therapeutic Choices - Episode 9

Risk of Secondary Malignancies in Heavily Pre-Treated Population

, , ,

A panel of experts discuss risk of secondary malignancies in heavily pre-treated populations.

Video content above is prompted by the following:

  • In R/R DLBCL, how do you select among the available options in the secondline setting?